Researchers from Circle Pharma Inc. have presented preclinical data for CID-078, a novel orally bioavailable cyclin A/B Rxl macrocycle being developed for the treatment of patients with lung cancer.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S.

A group of local bankers and finance executives is raising $35 million to open Georgia Skyline Bank in North Fulton. The bank ...

When you get right down to it, there is really nothing wrong with a late-model Firebird or Camaro that an infusion of horsepower won't cure. GM engineers hit a home run with the styling and handling ...